Project archive

The Fraunhofer project FibroPaths® aims to enable rapid and safe development of antifibrotic drugs.

The web application Genealyzer abstracts away mathematical and programmatical details in order to enable a convenient and customizable analysis of microarray data for large-scale reproducibility studies.

EASA, supported by the European Commission, has launched the new research project ”Cabin air quality assessment of long-term effects of contaminants” aimed at collecting additional scientific evidence concerning CAC events to root more extensive assessment of health risks and to support the evolution of aviation standards in this subject area.

The focus at Fraunhofer ITEM is on respiratory research. Over several decades, the institute’s scientists have built up their expertise in research on respiratory diseases such as asthma and COPD.

Fraunhofer ITEM researchers use the ex-vivo model of the isolated perfused rat lung (IPL). In this alternative model, they studied the transition of a fluorescence-labeled substance into the perfusate, which served as blood substitute in this model. Two different methods were used to generate aerosols with different droplet sizes.

In cooperation with CCC WERA Alliance the regional outreach of their respective Molecular Tumor Boards (MTBs) was measured.

In the RNAuto project, seven Fraunhofer institutes are collaborating to develop automated manufacturing technologies for mRNA-based therapeutics.

RISK-HUNT3R, short for “RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs”, is a European research and innovation project funded under the European Commission’s Horizon 2020 program. The project develops human-based testing strategies for next generation risk assessment.

Respiratory syncytial virus (RSV) usually causes mild airway infections in healthy adults. Fraunhofer ITEM scientists have established a model that mimics the viral infection ex vivo in viable human lung tissue (precision-cut lung slices – PCLS for short).

The focus of the Fraunhofer ITEM researchers in the ImmunAvatar project is on mimicking IBD. The use of both healthy tissue and tissue from IBD patients enables the identification of disease-specific differences, which can also be modulated in the model.